A solution to rapid antigen test shortages could be found close to home.

Brisbane-based bio-tech company Anteotech is pushing for TGA approval for its RATs, which are already being used overseas.

The company sells kits to Europe and has the capacity to make 12 million a year.

Chief Executive Derek Thomson has told Neil Breen, they just need to be given the green light here.

Press PLAY below to hear the full interview 

Image: Getty